QT
ARRY

Quantbot Technologies’s Array Biopharma Inc ARRY Stock Holding History

Quantbot Technologies’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-2,900
Closed -$134K – 1716
2019
Q2 		$134K Buy
+2,900
New +$81.4K 0.01% 690
2018
Q4 		– Sell
-7,639
Closed -$116K – 1627
2018
Q3 		$116K Sell
7,639
-8,670
-53% -$133K 0.01% 847
2018
Q2 		$273K Buy
+16,309
New +$259K 0.02% 692
2018
Q1 		– Sell
-9,879
Closed -$126K – 1650
2017
Q4 		$126K Sell
9,879
-8,326
-46% -$94.7K 0.01% 800
2017
Q3 		$223K Buy
18,205
+16,190
+803% +$150K 0.02% 677
2017
Q2 		$16K Sell
2,015
-12,508
-86% -$102K ﹤0.01% 1013
2017
Q1 		$129K Buy
14,523
+1,423
+11% +$15.1K 0.01% 736
2016
Q4 		$115K Buy
+13,100
New +$96.4K 0.01% 676
2015
Q4 		– Sell
-2,540
Closed -$11K – 1515
2015
Q3 		$11K Buy
+2,540
New +$15.1K ﹤0.01% 1078

Other funds holding ARRY

ASN
Advisory Services Network Atlanta, Georgia $8.83B AUM 38.5% 1-Year Est. Return

Quantbot Technologies's ARRY Position: Q3 2019 in Review

Quantbot Technologies sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 2,900 shares — an estimated $134K sold.

Quantbot Technologies first reported a position in ARRY in Q3 2015 and held it in 9 quarters. The position peaked at $273K in Q2 2018. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

  • Quantbot Technologies reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
  • Quantbot Technologies sold 2,900 Array Biopharma Inc shares in Q3 2019, an estimated $134K.
  • Quantbot Technologies first reported a position in Array Biopharma Inc in Q3 2015 and held it in 9 quarters.
  • Quantbot Technologies's Array Biopharma Inc position peaked at $273K in Q2 2018.
  • 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Quantbot Technologies's 13F filing for Q3 2019, filed 12 Nov 2019.